The World Health Organization has granted an emergency permit to the Covid-19 vaccine produced by Maryland-based Novavax and the Indian Serum Institute, opening the door to a vaccine, also known as Novavax, and distributing it to low-income countries around the world.
The announcement was made on Friday, about six weeks after the company submitted the application. The news of its approval prepared for a surge in cases caused by a new variant, Omicron, that governments around the world have re-imposed restrictions on the coronavirus and appear to be the most contagious form to date. I came sometimes. Its rapid spread underscores the urgency of tackling the unfairness of vaccines globally to eradicate pandemics.
Novavax’s approval, which was expected to make up a significant portion of the world’s vaccine supply, could bring significant changes. In February, Novavax announced an agreement to supply 1.1 billion doses to Covax, a UN-backed initiative to provide vaccines to low- and middle-income countries. In September, Covax needed to reduce its planned dose in 2021 by a quarter. This is because Novavax has not yet been licensed for the vaccine.
...
https://www.anandmarket.in/novavax-vaccine-wins-emergency-approval-from-the-w-h-o-2/